Early-stage health technology assessment of fractional flow reserve coronary computed tomography versus standard diagnostics in patients with stable chest pain in The Netherlands.
Iris W A BootR Nils PlankenAlexander W den HartogHubertus J M VrijhoefPublished in: PloS one (2024)
The early-stage HTA findings suggest that FFRct may reduce total healthcare spending, probability of incorrect diagnoses, and major adverse cardiovascular events compared to current diagnostics for patients with stable chest pain in the Dutch healthcare setting over one year. Future cost-effectiveness studies should determine a value-based pricing for FFRct and quantify the economic value of the anticipated therapeutic impact.
Keyphrases
- early stage
- healthcare
- cardiovascular events
- coronary artery disease
- computed tomography
- cardiovascular disease
- sentinel lymph node
- coronary artery
- health information
- public health
- magnetic resonance imaging
- emergency department
- current status
- type diabetes
- squamous cell carcinoma
- case control
- aortic stenosis
- mental health
- social media
- affordable care act
- adverse drug
- neoadjuvant chemotherapy
- ejection fraction
- locally advanced
- clinical evaluation